Skip to content

Xencor XNCR Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Amgen logo
AmgenAMGN
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Janux Therapeutics logo
Janux TherapeuticsJANX
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Absci Corporation logo
Absci CorporationABSI

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's software and technology licenses, net?
Xencor (XNCR) reported software and technology licenses, net of $498K in Q1 2026.
How has Xencor's software and technology licenses, net changed year-over-year?
Xencor's software and technology licenses, net decreased by 0.0% year-over-year, from $498K to $498K.
What is the long-term trend for Xencor's software and technology licenses, net?
Over 5 years (2020 to 2025), Xencor's software and technology licenses, net has grown at a 18.6% compound annual growth rate (CAGR), from $212K to $498K.